GRITTI, GIUSEPPE
GRITTI, GIUSEPPE
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 (Leukemia, (2021), 35, 9, (2710-2714), 10.1038/s41375-021-01299-x)
2021 Gritti, G; Raimondi, F; Bottazzi, B; Ripamonti, D; Riva, I; Landi, F; Alborghetti, L; Frigeni, M; Damiani, M; Mico, C; Fagiuoli, S; Lorini, F; Gandini, L; Novelli, L; Morgan, J; Owens, B; Kanhai, K; Reljanovic, G; Rizzi, M; Di Marco, F; Mantovani, A; Rambaldi, A
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
2021 Gritti, G; Raimondi, F; Bottazzi, B; Ripamonti, D; Riva, I; Landi, F; Alborghetti, L; Frigeni, M; Damiani, M; Mico, C; Fagiuoli, S; Lorini, F; Gandini, L; Novelli, L; Morgan, J; Owens, B; Kanhai, K; Reljanovic, G; Rizzi, M; Di Marco, F; Mantovani, A; Rambaldi, A
Skip pattern approach toward the early access of innovative anticancer drugs
2021 Apolone, G; Ardizzoni, A; Biondi, A; Bortolami, A; Cardone, C; Ciniselli, C; Conte, P; Crippa, C; de Braud, F; Duca, M; Gori, S; Gritti, G; Inno, A; Luksch, R; Lussana, F; Maio, M; Pasello, G; Perrone, F; Rambaldi, A; Rossi, G; Signorelli, D; Soverini, G; Valente, M; Verderio, P; Buzzetti, G
Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab
2020 Rambaldi, A; Gritti, G; Micò, M; Frigeni, M; Borleri, G; Salvi, A; Landi, F; Pavoni, C; Sonzogni, A; Gianatti, A; Binda, F; Fagiuoli, S; Di Marco, F; Lorini, F; Remuzzi, G; Whitaker, S; Demopulos, G
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Development of new therapeutic strategies in mature T-cell non-Hodgkin lymphomas
2017 Gritti, G
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: A GIMEMA Multicenter Phase II Trial
2014 Cortelezzi, A; Sciumè, M; Liberati, A; Vincenti, D; Cuneo, A; Reda, G; Laurenti, L; Zaja, F; Marasca, R; Chiarenza, A; Gritti, G; Orsucci, L; Storti, S; Angelucci, E; Cascavilla, N; Gobbi, M; Mauro, F; Morabito, F; Fabris, S; Piciocchi, A; Vignetti, M; Neri, A; Rossi, D; Giannarelli, D; Guarini, A; Foà, R
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
2012 Gritti, G; Reda, G; Maura, F; Piciocchi, A; Baldini, L; Molica, S; Neri, A; Cortelezzi, A